SMTL ID : 6lj4.1

Crystal structure of NDM-1 in complex with D-captopril derivative wss04146

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.15 Å

Oligo State

monomer

Ligands

2 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: D.96, C.180, H.222 Ligands: ZN.2, EF9.3 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:D.96, A:C.180, A:H.222 ZN.2: 5 residues within 4Å: Chain A: H.92, H.94, H.161 Ligands: ZN.1, EF9.3 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.92, A:H.94, A:H.161

1 x EF9: (3S)-1-[(2S)-2-methyl-3-sulfanyl-propanoyl]piperidine-3-carboxylic acid(Non-covalent)

EF9.3: 13 residues within 4Å: Chain A: M.39, V.45, W.65, H.94, D.96, H.161, C.180, L.190, G.191, N.192, H.222 Ligands: ZN.1, ZN.2 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:V.45, A:W.65 Hydrogen bonds: A:N.192 Water bridges: A:K.183 Salt bridges: A:K.183

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ma, G. et al., Structure-guided optimization of D-captopril for discovery of potent NDM-1 inhibitors. Bioorg.Med.Chem. (2020)

Release Date

2020-12-16

Peptides

Metallo-beta-lactamase type 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Metallo-beta-lactamase type 2

Related Entries With Identical Sequence